Abstract
These chapters demonstrate the variability of information available regarding the safety and efficacy of drugs used to prevent or treat bone loss in children. It is our collective responsibility to ensure that we do not withhold the benefits of a new drug from children due to concerns about possible side effects. Rather it is important to balance potential risks against potential benefits, carefully select study subjects, and obtain the resources to perform the necessary studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Klein, G.L. (2014). Conclusion: Whither (or Wither?) the Pharmacology of Pediatric Bone?. In: Klein, G. (eds) Bone Drugs in Pediatrics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7436-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7436-5_13
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7435-8
Online ISBN: 978-1-4899-7436-5
eBook Packages: MedicineMedicine (R0)